首页 > 市场调查报告书 > 製药

骨疾病

骨关节炎治疗市场规模、份额和成长分析（按解剖部位、药物类型、治疗类型、通路和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1896785

骨关节炎治疗市场规模、份额和成长分析（按解剖部位、药物类型、治疗类型、通路和地区划分）－2026-2033年产业预测

Osteoarthritis Treatment Market Size, Share, and Growth Analysis, By Anatomy, By Drug Type (Analgesics, Nonsteroidal Anti-Inflammatory Drugs ), By Treatment Type, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，骨关节炎治疗市场规模将达到 94.5 亿美元，到 2025 年将达到 102.5 亿美元，到 2033 年将达到 196.9 亿美元，预测期（2026-2033 年）的复合年增长率为 8.5%。

由于骨关节炎发生率上升和人口老化，骨关节炎治疗市场正经历强劲增长，对有效治疗方案的需求也随之增加。随着预期寿命的延长，骨关节炎高风险族群数量也在迅速增长，凸显了创新治疗方法在改善患者预后和生活品质方面的必要性。此外，人们对现有治疗方法和早期疗育重要性的认识不断提高，也显着促进了市场扩张。医疗机构正日益重视对患者进行骨关节炎相关知识、风险因素和各种治疗方案的教育，从而加速诊断和治疗启动。这种日益增长的认知正在推动对骨关节炎治疗产品的需求，预计未来几年将持续推动市场成长。

骨关节炎治疗司机

全球肥胖率的上升是骨关节炎发生率上升的重要原因之一。随着肥胖人群的增多，骨关节炎病例也相应增加。这一趋势导致对有效治疗方案的需求日益增长，因为肥胖患者通常需要采取全面的管理策略来控制病情。因此，医疗保健机构和製造商不得不探索和开发各种治疗方案，以满足不断增长的患者群体的需求。由此可见，肥胖与骨关节炎之间的相互关係正在显着影响骨关节炎治疗市场的趋势。

骨关节炎治疗市场的限制因素

骨关节炎治疗的一大障碍是缺乏有效的疾病修正治疗（DMT）。儘管各种治疗方案取得了进展，但缺乏能够延缓或逆转骨关节炎进展的有效治疗方法仍然是一项重大挑战。这种疗法的匮乏不仅使疾病管理更加复杂，而且对患者预后产生负面影响，并限制了治疗选择。因此，亟需在该领域寻求创新解决方案，以改善患者预后并提高综合骨关节炎治疗策略的有效性。

骨关节炎治疗市场趋势

骨关节炎治疗领域的一个显着市场趋势是转向个人化、多面向的管理策略。随着这种退化性关节疾病的盛行率不断上升，尤其是在老年人族群中，医疗专业人员正在抛弃传统的疼痛管理方法，例如非类固醇消炎剂（NSAIDs）和镇痛药。取而代之的是，他们正在采用结合药物和非药物疗法（包括物理治疗、营养指导和再生医学等先进干预措施）的个人化治疗方案。这种综合办法旨在应对骨关节炎的复杂性，透过认识到个别患者的需求和治疗反应可能存在显着差异，从而提高整体疗效和患者满意度。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Sanofi（France）
Pfizer Inc.（USA）
Novartis AG（Switzerland）
Johnson & Johnson（USA）
GlaxoSmithKline plc（UK）
AbbVie Inc.（USA）
Eli Lilly and Company（USA）
Bayer AG（Germany）
Merck & Co., Inc.（USA）
Bristol Myers Squibb（USA）
AstraZeneca plc（UK）
Amgen Inc.（USA）
Haleon plc（UK）
Seikagaku Corporation（Japan）
Ono Pharmaceutical Co., Ltd.（Japan）
Assertio Holdings, Inc.（USA）
Zimmer Biomet Holdings, Inc.（USA）
Ferring Pharmaceuticals（Switzerland）
Genascence Corporation（USA）

结论与建议

简介目录

Product Code: SQMIG35A2305

Osteoarthritis Treatment Market size was valued at USD 9.45 Billion in 2024 and is poised to grow from USD 10.25 Billion in 2025 to USD 19.69 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The osteoarthritis treatment market is experiencing robust growth, fueled by a rising incidence of the condition and a growing elderly population, which increases the demand for effective management solutions. As life expectancy improves, the number of individuals at risk for osteoarthritis has also surged, highlighting the need for innovative treatment approaches that enhance patient outcomes and quality of life. Additionally, heightened awareness around available therapies and the importance of early intervention is significantly influencing market expansion. Healthcare providers are increasingly focused on educating patients about osteoarthritis, associated risk factors, and diverse treatment options, resulting in more timely diagnoses and treatment initiation. This heightened awareness is driving demand for osteoarthritis treatment products, positioning the market for sustained growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Osteoarthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Osteoarthritis Treatment Market Segments Analysis

Global Osteoarthritis Treatment Market is segmented by anatomy, drug type, treatment type, distribution channel and region. Based on anatomy, the market is segmented into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis and small joint osteoarthritis. Based on drug type, the market is segmented into analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, visco supplementation agents and others. Based on treatment type, the market is segmented into medication, surgery and therapy. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Osteoarthritis Treatment Market

The rising global prevalence of obesity plays a crucial role in the growing incidence of osteoarthritis. As more individuals struggle with obesity, the number of osteoarthritis cases correspondingly increases. This trend leads to a heightened demand for effective treatment solutions, as those affected by obesity often need extensive management strategies to address their condition. Consequently, healthcare providers and manufacturers are compelled to explore and develop a range of therapeutic options to meet the needs of this expanding patient population. Thus, the interconnection between obesity and osteoarthritis significantly influences the dynamics within the osteoarthritis treatment market.

Restraints in the Osteoarthritis Treatment Market

A key obstacle in the osteoarthritis treatment landscape is the unavailability of disease-modifying therapies. Although there have been advancements in various treatment options, the deficit of effective therapies that can slow or reverse the progression of osteoarthritis poses a considerable challenge. This shortfall not only complicates the overall management of the condition but also adversely affects the results for patients, leaving them with limited alternatives for their care. The need for innovative solutions in this area is critical to improve patient outcomes and enhance the effectiveness of overall treatment strategies for osteoarthritis.

Market Trends of the Osteoarthritis Treatment Market

A notable market trend in the Osteoarthritis Treatment sector is the shift towards personalized and multimodal management strategies. As the prevalence of this degenerative joint disease rises, particularly among the aging population, healthcare professionals are moving beyond conventional pain management techniques, such as NSAIDs and analgesics. Instead, they are adopting tailored treatment plans that incorporate a blend of pharmacologic and non-pharmacologic therapies, including physical therapy, nutritional guidance, and advanced interventions like regenerative medicine. This holistic approach aims to address the complex nature of osteoarthritis, recognizing that individual patient needs and responses to treatment can vary significantly, thus enhancing overall efficacy and patient satisfaction.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis

Global Osteoarthritis Treatment Market Size by Anatomy & CAGR (2026-2033)

Market Overview
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Small Joint Osteoarthritis

Global Osteoarthritis Treatment Market Size by Drug Type & CAGR (2026-2033)

Market Overview
Analgesics
- Acetaminophen
- Opioids
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Ibuprofen
- Naproxen
Corticosteroids
- Oral Corticosteroids
- Injectable Corticosteroids
Visco Supplementation Agents
- Hyaluronic Acid
Others
- Disease-Modifying Osteoarthritis Drugs (DMOADs)

Global Osteoarthritis Treatment Market Size by Treatment Type & CAGR (2026-2033)

Market Overview
Medication
Surgery
- Joint Replacement
- Arthroscopy
- Osteotomy
Therapy
- Physical Therapy
- Occupational Therapy

Global Osteoarthritis Treatment Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Osteoarthritis Treatment Market Size & CAGR (2026-2033)

North America (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- US
- Canada
Europe (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haleon plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seikagaku Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ono Pharmaceutical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Assertio Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genascence Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments